291 related articles for article (PubMed ID: 37431857)
1. A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines.
Hong M; Lan T; Li Q; Li B; Yuan Y; Xu F; Wang W
Gut Microbes; 2023; 15(1):2233146. PubMed ID: 37431857
[TBL] [Abstract][Full Text] [Related]
2. Interaction between gut microbiota and COVID-19 and its vaccines.
Leung JSM
World J Gastroenterol; 2022 Oct; 28(40):5801-5806. PubMed ID: 36353201
[TBL] [Abstract][Full Text] [Related]
3. Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms.
Lynn DJ; Benson SC; Lynn MA; Pulendran B
Nat Rev Immunol; 2022 Jan; 22(1):33-46. PubMed ID: 34002068
[TBL] [Abstract][Full Text] [Related]
4. Current Drug Targets for Gut Microbiota Biocorrection during the SARS-CoV-2 Pandemic: A Systematic Review.
Sankova MV; Nikolenko VN; Oganesyan MV; Bakhmet AA; Gavryushova LV; Sankov SV; Sinelnikov MY
Curr Drug Targets; 2022; 23(11):1099-1125. PubMed ID: 35440305
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Communication Strategies for Mitigating COVID-19 Vaccine-Specific Hesitancy in Canada.
Merkley E; Loewen PJ
JAMA Netw Open; 2021 Sep; 4(9):e2126635. PubMed ID: 34591105
[TBL] [Abstract][Full Text] [Related]
6. Influence of Microbiota on Vaccine Effectiveness: "Is the Microbiota the Key to Vaccine-induced Responses?".
Hong SH
J Microbiol; 2023 May; 61(5):483-494. PubMed ID: 37052795
[TBL] [Abstract][Full Text] [Related]
7. Correlation of gut microbiota and metabolic functions with the antibody response to the BBIBP-CorV vaccine.
Tang B; Tang L; He W; Jiang X; Hu C; Li Y; Zhang Y; Pang K; Lei Y; Li S; Liu S; Wang S; Yang M; Li Z; Zhao F; Yang S
Cell Rep Med; 2022 Oct; 3(10):100752. PubMed ID: 36228621
[TBL] [Abstract][Full Text] [Related]
8. Host factors and vaccine efficacy: Implications for COVID-19 vaccines.
Falahi S; Kenarkoohi A
J Med Virol; 2022 Apr; 94(4):1330-1335. PubMed ID: 34845730
[TBL] [Abstract][Full Text] [Related]
9. Stability of gut microbiome after COVID-19 vaccination in healthy and immuno-compromised individuals.
Boston RH; Guan R; Kalmar L; Beier S; Horner EC; Beristain-Covarrubias N; Yam-Puc JC; Pereyra Gerber P; Faria L; Kuroshchenkova A; Lindell AE; Blasche S; Correa-Noguera A; Elmer A; Saunders C; Bermperi A; Jose S; Kingston N; ; Grigoriadou S; Staples E; Buckland MS; Lear S; Matheson NJ; Benes V; Parkinson C; Thaventhiran JE; Patil KR
Life Sci Alliance; 2024 Apr; 7(4):. PubMed ID: 38316462
[TBL] [Abstract][Full Text] [Related]
10. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.
Wang M; Zhang Y; Li C; Chang W; Zhang L
Front Immunol; 2023; 14():1180336. PubMed ID: 37205106
[TBL] [Abstract][Full Text] [Related]
11. Association between Gut Microbiota and SARS-CoV-2 Infection and Vaccine Immunogenicity.
Ng HY; Leung WK; Cheung KS
Microorganisms; 2023 Feb; 11(2):. PubMed ID: 36838417
[TBL] [Abstract][Full Text] [Related]
12. Impact of the Host Microbiome on Vaccine Responsiveness: Lessons Learned and Future Perspective.
Stefanetti G; Kasper DL
Biochemistry; 2022 Dec; 61(24):2849-2855. PubMed ID: 35993915
[TBL] [Abstract][Full Text] [Related]
13. Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome.
Wang Y; Wu G; Zhao L; Wang W
mBio; 2022 Apr; 13(2):e0380121. PubMed ID: 35254129
[TBL] [Abstract][Full Text] [Related]
14. Dietary intervention with functional foods modulating gut microbiota for improving the efficacy of COVID-19 vaccines.
Oh S; Seo H
Heliyon; 2023 May; 9(5):e15668. PubMed ID: 37124341
[TBL] [Abstract][Full Text] [Related]
15. Understanding Host Immunity and the Gut Microbiota Inspires the New Development of Vaccines and Adjuvants.
Yakabe K; Uchiyama J; Akiyama M; Kim YG
Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33530627
[TBL] [Abstract][Full Text] [Related]
16. Considerations for Gut Microbiota and Probiotics in Patients with Diabetes Amidst the Covid-19 Pandemic: A Narrative Review.
Barengolts E; Smith ED
Endocr Pract; 2020 Oct; 26(10):1186-1195. PubMed ID: 33471720
[TBL] [Abstract][Full Text] [Related]
17. Increasing Efficacy of Covid-19 Vaccines by Lifestyle Interventions.
Gasmi A; Kumar Mujawdiya P; Noor S; Piscopo S; Résimont S; Menzel A
Arch Razi Inst; 2022 Oct; 77(5):1527-1538. PubMed ID: 37123146
[TBL] [Abstract][Full Text] [Related]
18. The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients.
Alexander JL; Mullish BH; Danckert NP; Liu Z; Olbei ML; Saifuddin A; Torkizadeh M; Ibraheim H; Blanco JM; Roberts LA; Bewshea CM; Nice R; Lin S; Prabhudev H; Sands C; Horneffer-van der Sluis V; Lewis M; Sebastian S; Lees CW; Teare JP; Hart A; Goodhand JR; Kennedy NA; Korcsmaros T; Marchesi JR; Ahmad T; Powell N
EBioMedicine; 2023 Feb; 88():104430. PubMed ID: 36634565
[TBL] [Abstract][Full Text] [Related]
19. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
20. Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic.
Kazemian N; Kao D; Pakpour S
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
